Promoting PGC-1α-driven mitochondrial biogenesis is detrimental in pressure-overloaded mouse hearts

Georgios Karamanlidis1, Lorena Garcia-Menendez1, Stephen C Kolwicz1

  • 1Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington.

Insights

Moderate overexpression of peroxisome proliferator-activated receptor-γ coactivator alpha (PGC)-1α in the heart compromises survival and does not improve cardiac function during pressure overload, suggesting it is not a suitable therapeutic target for heart failure.

Area of Science:

  • Cardiology
  • Mitochondrial Biology
  • Molecular Medicine

Background:

  • Mitochondrial dysfunction is linked to heart failure.
  • The peroxisome proliferator-activated receptor-γ coactivator (PGC)-1α pathway is downregulated in heart failure models.

Purpose of the Study:

  • To investigate if PGC-1α is a viable therapeutic target for heart failure.
  • To assess the effects of moderate PGC-1α overexpression on mitochondrial biogenesis and cardiac function.

Main Methods:

  • Utilized a transgenic mouse model with moderate cardiac PGC-1α overexpression (approx. 3-fold).
  • Assessed baseline cardiac function, energetics, and mitochondrial parameters.
  • Evaluated responses to dobutamine stress (in vivo) and high workload (ex vivo).
  • Induced pressure overload using transverse aortic constriction (TAC) to study long-term effects on survival and cardiac function.

Main Results:

  • Moderate PGC-1α overexpression led to minor increases in citrate synthase activity and mitochondria size without affecting baseline cardiac energetics or function.
  • Dobutamine stress response was attenuated in transgenic mice.
  • Transverse aortic constriction resulted in higher acute mortality in transgenic mice.
  • Transgenic mice exhibited worsened cardiac dysfunction and increased left ventricular dimensions post-TAC, despite maintained mitochondrial gene expression and citrate synthase activity.

Conclusions:

  • Moderate cardiac PGC-1α overexpression compromises acute survival during pressure overload.
  • This level of PGC-1α overexpression does not improve cardiac function in a mouse model of chronic pressure overload.
  • PGC-1α may not be an appropriate therapeutic target for increasing mitochondrial biogenesis in heart failure under these conditions.

Related Concept Videos